Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

gallium Ga 68 AIP-301

A radioconjugate composed of AIP-301, a molecule targeting the tumor-associated antigen (TAA) epidermal growth factor receptor 2 (HER2, EGFR2, ERBB2), that is linked to the radionuclide gallium (Ga) 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration of gallium Ga 68 AIP-301, the AIP-301 moiety targets and binds to HER2-expressing tumor cells. This facilitates both the detection of HER2-expressing tumor cells and the assessment of responses to AIP-303 and other HER2-targeted chemotherapeutic agents during PET/CT. HER2, a tyrosine kinase, is overexpressed on the cell surfaces of various tumor cell types.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:68Ga-AIP 301
68Ga-AIP-301
68Ga-AIP301
gallium Ga 68 AIP 301
gallium Ga 68 AIP301
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search